Post Stabilisation Notice - GlaxoSmithKline

16-Oct-19

Not for distribution, directly or indirectly, in or into the United States or any jurisdiction in

which such distribution would be unlawful.

GlaxoSmithKline Capital plc

Post-stabilisation Period Announcement

Further to the pre-stabilisation period announcement dated 16/09/20191 Deutsche Bank AG London (contact: DCM Syndication TA; telephone: 0207 54 54153 hereby gives notice that no stabilisation (within the meaning of Article 3.2(d) of the Market Abuse Regulation (EU/596/2014) or the rules of the Financial Conduct Authority)2 was undertaken by the Stabilisation Manager(s)3 named below in relation to the offer of the following securities.

The Securities:

Issuer: GlaxoSmithKline Capital plc

Guarantor (if any): GlaxoSmithKline plc

Aggregate nominal amount: EUR 2.5bn

Description: GlaxoSmithKline EUR 2y FRN and 2/4y FXD

Stabilisation Manager(s): BNPP, CS, DB, MS

Offer Price: 100.650 / 100.289 / 100.184